Clinical Trial Update: A Study of Oxycodone/Naloxone Controlled-release Tablets (OXN) to Assess Analgesic Efficacy and Management of Opioid-induced Constipation (OIC) in Opioid-experienced Subjects With Moderate to Severe Chronic Low Back Pain [Phase 3]

View source ↗

Summary

Phase 3 study evaluating analgesic efficacy and opioid-induced constipation management of Oxycodone/Naloxone controlled-release tablets in adults with chronic l…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Low Back Pain
• Opioid-induced Constipation

Drugs mentioned

• Oxycodone/Naloxone controlled-release tablets (OXN) (oxycodone/naloxone)

Snippet

Sponsor: Purdue Pharma LP | Conditions: Low Back Pain | Phase 3 | Status: COMPLETED